These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 32583902

  • 1. Open-Label, Multi-Dose, Pilot Safety Study of Injection of OnabotulinumtoxinA Toward the Otic Ganglion for the Treatment of Intractable Chronic Cluster Headache.
    Crespi J, Bratbak D, Dodick DW, Matharu M, Solheim O, Gulati S, Berntsen EM, Tronvik E.
    Headache; 2020 Sep; 60(8):1632-1643. PubMed ID: 32583902
    [Abstract] [Full Text] [Related]

  • 2. Pilot Study of Injection of OnabotulinumtoxinA Toward the Sphenopalatine Ganglion for the Treatment of Classical Trigeminal Neuralgia.
    Crespi J, Bratbak D, Dodick DW, Matharu M, Jamtøy KA, Tronvik E.
    Headache; 2019 Sep; 59(8):1229-1239. PubMed ID: 31342515
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Long-Term Outcome of Patients With Intractable Chronic Cluster Headache Treated With Injection of Onabotulinum Toxin A Toward the Sphenopalatine Ganglion - An Observational Study.
    Aschehoug I, Bratbak DF, Tronvik EA.
    Headache; 2018 Nov; 58(10):1519-1529. PubMed ID: 30216444
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program.
    Aurora SK, Winner P, Freeman MC, Spierings EL, Heiring JO, DeGryse RE, VanDenburgh AM, Nolan ME, Turkel CC.
    Headache; 2011 Oct; 51(9):1358-73. PubMed ID: 21883197
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Onabotulinumtoxin-A treatment in Greek patients with chronic migraine.
    Vikelis M, Argyriou AA, Dermitzakis EV, Spingos KC, Mitsikostas DD.
    J Headache Pain; 2016 Dec; 17(1):84. PubMed ID: 27640152
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A multi-center double-blind pilot comparison of onabotulinumtoxinA and topiramate for the prophylactic treatment of chronic migraine.
    Cady RK, Schreiber CP, Porter JA, Blumenfeld AM, Farmer KU.
    Headache; 2011 Jan; 51(1):21-32. PubMed ID: 21070228
    [Abstract] [Full Text] [Related]

  • 15. A double-blind comparison of onabotulinumtoxina (BOTOX) and topiramate (TOPAMAX) for the prophylactic treatment of chronic migraine: a pilot study.
    Mathew NT, Jaffri SF.
    Headache; 2009 Jan; 49(10):1466-78. PubMed ID: 19912346
    [Abstract] [Full Text] [Related]

  • 16. The Efficacy of Botulinum Toxin in Cluster Headache: A Systematic Review.
    Freund B, Kotchetkov IS, Rao A.
    J Oral Facial Pain Headache; 2020 Jan; 34(2):129–134. PubMed ID: 31560734
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinical profile of botulinum toxin A in patients with chronic headaches and cervical dystonia: a prospective, open-label, longitudinal study conducted in a naturalistic clinical practice setting.
    Dowson AJ, Kilminster SG, Salt R.
    Drugs R D; 2008 Jan; 9(3):147-58. PubMed ID: 18457467
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.